EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Regulation of interleukin 2 receptor expression on a human cytotoxic T lymphocyte clone, synergism between alloantigenic stimulation and interleukin 2


Journal of Immunology 136(5): 1693-1699
Regulation of interleukin 2 receptor expression on a human cytotoxic T lymphocyte clone, synergism between alloantigenic stimulation and interleukin 2
A human T cell clone (termed 40.2.6) established from a rejected human kidney allograft has been studied for its ability to express membrane IL 2 receptors in response to antigen (irradiated cells from the graft's donor) and recombinant IL 2 (rec-IL 2). On antigenic stimulation, the 40.2.6 clone produced low levels (0.15 U/ml) of IL 2 (peak at 24 hr) and incorporated (3H)thymidine (peak at 48 hr). This incorporation was strongly enhanced on addition of rec-IL 2 and was inhibited by the 33B31 antibody, an anti-human IL 2 receptor monoclonal antibody (Mab). The 125I-labeled 33B31 Mab has been used to quantify the density of IL 2 receptors on 40.2.6 cells. Cells not re-exposed to antigen or rec-IL 2 had a level of 33B31-binding sites which declined rapidly (10% of starting value after 2 days). This level remained much more stable when rec-IL 2 (1 U/ml) was present in the medium (80% at day 2). Antigen induced a three- to eightfold increase in the level of 33B31-binding sites which peaked at 24 hr and then declined. When a similar antigenic stimulation was performed in the presence of rec-IL 2 (1 U/ml), the level of 33B31-binding sites peaked at a higher value (eight- to 20-fold increase at day 2), and its subsequent decline was slower. These potentiating effects of rec-IL 2 were dose-dependent and occurred at low concentrations corresponding to the saturation by rec-IL 2 of high affinity IL 2 receptor sites. Finally, high affinity IL 2 receptors, as measured by the binding of 35S-labeled rec-IL 2, were found to be similarly up-regulated by antigen and rec-IL 2. Together, our results obtained on a monoclonal human T cell population with highly purified rec-IL 2 demonstrate that rec-IL 2 and antigen act in synergy to induce the expression of both high and low affinity membrane IL 2 receptors.


Accession: 006288807

PMID: 2936808



Related references

A CD4+ cytotoxic T-lymphocyte clone to a conserved epitope on human immunodeficiency virus type 1 p24: cytotoxic activity and secretion of interleukin-2 and interleukin-6. Journal of Virology 66(1): 608-611, 1992

A cd4 positive cytotoxic t lymphocyte clone to a conserved epitope on human immunodeficiency virus type 1 p24 cytotoxic activity and secretion of interleukin 2 and interleukin 6. Journal of Virology 66(1): 608-611, 1992

Down regulation of interleukin 1 receptor expression by interleukin 1 and fate of internalized iodine 125 labeled interleukin 1 beta in a human large of granular lymphocyte cell line. Journal of Immunology 137(10): 3183-3188, 1986

Adoptive immunotherapy of a syngeneic murine leukemia with a tumor specific cytotoxic t cell clone and recombinant human interleukin 2 correlation with clonal interleukin 2 receptor expression. Journal of Immunology 136(9): 3496-3501, 1986

Recombinant human interleukin 2 functions only as a differentiative signal for cytotoxic t lymphocyte induction in concert with interleukin 2 receptor expression regulatory human lymphokines but does not support t cell growth. Lymphokine Research 3(4): 247, 1984

Regulation of growth and interleukin 2 receptor expression on mouse t lymphocyte clone. Cell Structure & Function 10(4): 476, 1985

Regulation of interleukin 2 receptor expression on murine cytotoxic T lymphocyte clones. Journal of Immunology 132(2): 839-844, 1984

Interleukin 2 and interleukin 2 inhibitors in human serum and synovial fluid. II. Mitogenic stimulation, interleukin 2 production and interleukin 2 receptor expression in rheumatoid arthritis, psoriatic arthritis and Reiter's syndrome. Journal of Rheumatology 16(7): 897-903, 1989

Evidence for interleukin-1-independent stimulation of interleukin-12 and down-regulation by interleukin-10 in Helicobacter pylori-infected murine dendritic cells deficient in the interleukin-1 receptor. Fems Immunology and Medical Microbiology 47(3): 414-419, 2006

P815 specific cytotoxic t lymphocyte clone dependent upon tumor cell stimulation and exogenous interleukin 2 for proliferation. Lotze, M T And O J Finn (Ed ) Ucla (University Of California-Los Angeles) Symposia on Molecular And Cellular Biology New Series, Vol 135 Cellular Immunity And The Immunotherapy Of Cancer; Cetus, Immunex, And Triton Biosciences-Ucla Symposia Colloquium, Park City, Utah, Usa, January 27-February 3, Xxxiii+432p Wiley-Liss: New York, New York, Usa; Chichester, England, Uk Illus 303-306, 1990